Robert Greg Sorensen

Title: Robert Greg Sorensen: Innovator in Canine Vaccines

Introduction

Robert Greg Sorensen is an accomplished inventor based in the United States. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for dogs. His work focuses on protecting canines from various diseases caused by Bordetella bronchiseptica and other pathogens.

Latest Patents

Robert Greg Sorensen holds a notable patent titled "Canine Vaccines Against Bordetella Bronchiseptica." This invention relates to vaccines and methods for protecting dogs against diseases caused by Bordetella bronchiseptica. The patent also encompasses combination vaccines aimed at safeguarding dogs from a range of canine pathogens, including those responsible for infectious tracheobronchitis, canine distemper, infectious canine hepatitis, respiratory diseases, and leptospirosis. Despite his impactful work, he currently has 1 patents listed.

Career Highlights

Sorensen is associated with Pfizer Products Inc., a leading company in the pharmaceutical industry. His role at Pfizer has allowed him to contribute to the advancement of veterinary vaccines, enhancing the health and well-being of dogs.

Collaborations

Throughout his career, Robert has collaborated with notable colleagues, including Paul Joseph Dominowski and Joseph Claude Frantz. These partnerships have fostered innovation and development in the field of veterinary medicine.

Conclusion

Robert Greg Sorensen's work in developing canine vaccines demonstrates his commitment to improving animal health. His contributions to veterinary science are invaluable, and his ongoing efforts continue to benefit the canine population.